From: New GOLD classification: longitudinal data on group assignment
Variable | Univariate analysis | ||
---|---|---|---|
Relative risk | 95%CI | p | |
Age | 1.032 | 1.004-1.062 | 0.027 |
Gender (female) | 1.542 | 0.761-3.122 | 0.229 |
Active smoking | 1.086 | 0.637-1.853 | 0.761 |
BMI | 1.021 | 0.983-1.060 | 0.280 |
Inhaled β2-agonist | 0.824 | 1.487-1.393 | 0.470 |
Inhaled anticholinergic | 0.905 | 0.529-1.550 | 0.717 |
Inhaled corticosteroid | 1.065 | 0.639-1.774 | 0.809 |
Charlson index | 1.047 | 0.898-1.220 | 0.557 |
Anxiety | 1.021 | 0.967-1.077 | 0.450 |
Depression | 1.096 | 1.027-1.170 | 0.006 |
FEV1%* | 1.065 | 1.034-1.096 | <0.001 |
mMRC* | 1.956 | 1.494-2.562 | <0.001 |
CAT* | 1.162 | 1,106-1.221 | <0.001 |
Exacerbations ≥2 or hospitalization ≥1* | 0.981 | 0.182-5.285 | 0.982 |
BODE index* | 2.136 | 1.664-2.742 | <0.001 |
Multivariate analysis | |||
Relative risk | 95%CI | p | |
CAT | 1.138 | 1.074-1.206 | <0.001 |
BODE index | 2.012 | 1.487-2.722 | <0.001 |